AP306 first-in-class pan phosphate transporter inhibitor (NaPi-IIb, PiT-1, PiT-2) for hyperphosphatemia in dialysis CKD patients; planned global Phase 2b across US/China with Alebund partner
No detailed funding rounds available.
Total known funding: